Institutional Ownership Syndax Pharmaceuticals Inc (SNDX)
This table provides information about the institutional ownership of Syndax Pharmaceuticals Inc (SNDX). We have compiled data on the 228 institutions that hold shares in the stock, with a total of 88.4 Million shares, which have been reported (via 13F filing form) to have a value of $1.48 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ghost Tree Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
450,000
shares
|
$7.52 Million
3.25% of portfolio
|
Q3 2024
Added 28.57%
|
|
|
Crestline Management, LP
Fort Worth, TX |
Nov 13, 2024 Q3 2024 |
428,538
shares
|
$7.16 Million
0.44% of portfolio
|
Q3 2024
Added 199.09%
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Nov 13, 2024 Q3 2024 |
425,000
shares
|
$7.1 Million
0.04% of portfolio
|
Q3 2024
New holding
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
423,910
shares
|
$7.08 Million
0.48% of portfolio
|
Q3 2024
Added 9.44%
|
|
|
Palo Alto Investors LP
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
405,193
shares
|
$6.77 Million
1.07% of portfolio
|
Q1 2024
Reduced 14.26%
|
|
|
Silverarc Capital Management, LLC
|
Nov 14, 2024 Q3 2024 |
378,746
shares
|
$6.33 Million
1.81% of portfolio
|
Q3 2024
Added 2.36%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
367,177
shares
|
$6.13 Million
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 14, 2024 Q3 2024 |
361,825
shares
|
$6.04 Million
0.01% of portfolio
|
Q3 2024
Reduced 30.27%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
352,358
shares
|
$5.88 Million
0.01% of portfolio
|
Q3 2024
Added 140.28%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2024 Q3 2024 |
350,206
shares
|
$5.85 Million
1.1% of portfolio
|
Q3 2024
New holding
|
|
|
Exodus Point Capital Management, LP
New York, NY |
Nov 12, 2024 Q3 2024 |
318,394
shares
|
$5.32 Million
0.04% of portfolio
|
Q3 2024
Reduced 49.12%
|
|
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
Nov 13, 2024 Q3 2024 |
259,500
shares
|
$4.33 Million
0.42% of portfolio
|
Q3 2024
Added 13.57%
|
|
|
Macquarie Group LTD
Australia, C3 |
Nov 14, 2024 Q3 2024 |
243,352
shares
|
$4.06 Million
0.01% of portfolio
|
Q3 2024
Added 0.18%
|
|
|
Peregrine Capital Management LLC
|
Oct 24, 2024 Q3 2024 |
199,086
shares
|
$3.32 Million
0.12% of portfolio
|
Q3 2024
Added 0.21%
|
|
|
Twinbeech Capital LP
Purchase, NY |
Nov 14, 2024 Q3 2024 |
198,579
shares
|
$3.32 Million
0.08% of portfolio
|
Q3 2024
Added 18.4%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
187,629
shares
|
$3.13 Million
0.0% of portfolio
|
Q3 2024
Added 143.38%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
187,463
shares
|
$3.13 Million
0.03% of portfolio
|
Q3 2024
Reduced 28.14%
|
|
|
Rafferty Asset Management, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
171,522
shares
|
$2.86 Million
0.01% of portfolio
|
Q3 2024
Reduced 3.6%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
168,706
shares
|
$2.82 Million
0.0% of portfolio
|
Q3 2024
Added 65.35%
|
|
|
Swiss National Bank
Zurich, V8 |
Nov 07, 2024 Q3 2024 |
149,400
shares
|
$2.49 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.8%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
146,438
shares
|
$2.45 Million
0.0% of portfolio
|
Q3 2024
Added 17.01%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
137,447
shares
|
$2.3 Million
0.0% of portfolio
|
Q3 2024
Reduced 10.38%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
133,541
shares
|
$2.23 Million
0.0% of portfolio
|
Q3 2024
Reduced 12.9%
|
|
|
Propel Bio Management, LLC
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
133,259
shares
|
$2.23 Million
1.49% of portfolio
|
Q3 2024
Added 60.05%
|
|
|
Simplify Asset Management Inc.
New York, NY |
Nov 12, 2024 Q3 2024 |
122,185
shares
|
$2.04 Million
0.13% of portfolio
|
Q3 2024
Added 62.5%
|